About
About Us
Leadership
Scientific Advisory Board
Locations
Development History
Awards
Investor
Announcements
Stock Trend
Investor Interaction
ESG
ESG
ESG Concept
ESG Policy
Media Center
Video Center
Image Center
Product & Services
API & Intermediate
Portfolio
R&D
Patents
CDMO
One-Stop Service
Platforms
Capacity
Finished Dosage Form
Product Service
R&D
Aesthetic & Care Ingredients
Portfolio
R&D
Technology Platforms
DS Technology Platforms
Flow Chemistry
Synthetic Biology & Biocatalysis
Crystallization & Particle Engineering
Peptide
High Potency Compound
Conjugate Library Service
Oligonucleotide Synthesis
Preparation & Purification
DP Technology Platforms
Controlled-release Formulation Development
Taste Masking Technology
Particle Flow Simulation
Technical Support Centers
Analytical Testing Center
Process Safety Center
News
Events
News Room
Careers
Join Us
Meet our People
Talent Strategy
Working at Apeloa
CN
Contact Us
About
About Us
Leadership
Scientific Advisory Board
Locations
Development History
Awards
Investor
Announcements
Stock Trend
Investor Interaction
ESG
ESG
ESG Concept
ESG Policy
Media Center
Video Center
Image Center
Product & Services
API & Intermediate
Portfolio
R&D
Patents
CDMO
One-Stop Service
Platforms
Capacity
Finished Dosage Form
Product Service
R&D
Aesthetic & Care Ingredients
Portfolio
R&D
Technology Platforms
DS Technology Platforms
Flow Chemistry
Synthetic Biology & Biocatalysis
Crystallization & Particle Engineering
Peptide
High Potency Compound
Conjugate Library Service
Oligonucleotide Synthesis
Preparation & Purification
DP Technology Platforms
Controlled-release Formulation Development
Taste Masking Technology
Particle Flow Simulation
Technical Support Centers
Analytical Testing Center
Process Safety Center
News
Events
News Room
Careers
Join Us
Meet our People
Talent Strategy
Talent Development
Talent Policy
Working at Apeloa
Contact Us
CN
喜讯 | 普洛药业荣膺金华“十佳外贸企业”称号
author:
Aperoa
2023.Jun.25
近日,金华市召开“地瓜经济”提能升级“一号开放工程”暨贸易枢纽建设推进会。会上,40家企业因对外开放业绩突出受表彰。其中,普洛药业下属子公司浙江横店普洛进出口有限公司荣膺“十佳外贸企业”。
近年来,普洛药业积极应对全球形势变化,持续强化企业核心竞争力,不断加快推进国际化发展战略进程,积极拓展海外市场,凭借高效率的技术研发能力、高标准的合规能力、良好的成本控制能力和优秀的BD团队获得众多海外客户的认可,与众多国外大型制药公司、销售商建立了战略合作关系,经营业绩保持持续增长,“原料药出口”位列全国第2位(浙江第1位)。2022年度,公司营收达到105亿元,实现五连增,出口业务占比43%,同比增长30%;充分体现了企业的综合实力和全球市场竞争力,有力助推了金华市医药经济高质量发展。
Previous:
none
Next:
none
Back to list
We value your privacy
To enhance user experience and protect your rights and privacy, please review our
Privacy Policy
and
Legal Statement
. By clicking "Accept All", you acknowledge and accept the above terms.
Reject All
Accept All